Li Xue Selected Research

Urinary Bladder Neoplasms (Bladder Cancer)

8/2021	TMEM88 exhibits an antiproliferative and anti-invasive effect in bladder cancer by downregulating Wnt/β-catenin signaling.
6/2013	Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li Xue Research Topics

Disease

38	Neoplasms (Cancer) 04/2024 - 07/2003
12	Inflammation (Inflammations) 07/2023 - 12/2009
10	Parkinson Disease (Parkinson's Disease) 01/2024 - 09/2012
9	Neoplasm Metastasis (Metastasis) 08/2023 - 01/2015
9	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 01/2015
7	Reperfusion Injury 10/2023 - 11/2011
6	Rheumatoid Arthritis 12/2023 - 07/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2010
6	Carcinogenesis 01/2021 - 01/2015
5	Hypertension (High Blood Pressure) 08/2023 - 01/2015
5	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2015
5	Myocardial Infarction 01/2022 - 06/2010
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019 - 06/2013
4	Major Depressive Disorder (Major Depressive Disorders) 04/2024 - 01/2021
4	Type 2 Diabetes Mellitus (MODY) 12/2023 - 12/2005
4	Myocardial Ischemia (Ischemic Heart Diseases) 10/2023 - 03/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2012
4	Ischemia 01/2021 - 11/2011
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 11/2008
4	Atherosclerosis 01/2020 - 01/2018
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024 - 01/2023
3	Prolactinoma (Prolactinomas) 02/2024 - 01/2020
3	Non-Muscle Invasive Bladder Neoplasms 09/2023 - 10/2020
3	Coronary Disease (Coronary Heart Disease) 08/2023 - 08/2007
3	Pituitary Neoplasms (Pituitary Adenoma) 01/2023 - 01/2020
3	Hypoxia (Hypoxemia) 12/2022 - 03/2015
3	Wounds and Injuries (Trauma) 10/2022 - 06/2010
3	Leukemia 01/2022 - 01/2017
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 02/2012
3	Atherosclerotic Plaque (Atheroma) 01/2019 - 11/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 03/2015 - 11/2007
2	Autoimmune Diseases (Autoimmune Disease) 10/2023 - 07/2013
2	Carcinoma (Carcinomatosis) 10/2023 - 01/2013
2	Stomach Neoplasms (Stomach Cancer) 10/2023 - 09/2020
2	Hematuria 09/2023 - 08/2023
2	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 11/2021
2	Necrosis 04/2023 - 03/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2023 - 03/2021
2	Hyperplasia 03/2023 - 08/2018
2	Pathologic Constriction (Stenosis) 01/2023 - 11/2007
2	Infections 01/2023 - 01/2022
2	Hemorrhage 10/2022 - 09/2022
2	Bites and Stings (Sting) 08/2022 - 01/2022
2	Heart Failure 01/2022 - 03/2018
2	Fibrosis (Cirrhosis) 01/2022 - 12/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 08/2021 - 06/2013

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2017
19	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2012
8	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 07/2012
8	Aldehyde DehydrogenaseIBA 01/2023 - 09/2011
7	CytokinesIBA 01/2021 - 11/2011
6	Transcription Factors (Transcription Factor)IBA 04/2024 - 01/2015
6	Messenger RNA (mRNA)IBA 10/2023 - 01/2013
5	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2013
5	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 11/2016
4	Antidepressive Agents (Antidepressants)IBA 04/2024 - 01/2021
4	Toll-Like Receptor 4IBA 07/2023 - 01/2017
4	Therapeutic UsesIBA 01/2023 - 12/2006
3	Dopamine Agonists (Dopamine Agonist)IBA 02/2024 - 01/2020
3	LipopolysaccharidesIBA 01/2023 - 01/2017
3	CateninsIBA 11/2021 - 01/2021
3	AldehydesIBA 01/2021 - 08/2007
3	ChemokinesIBA 01/2021 - 11/2011
3	Apolipoproteins E (ApoE)IBA 01/2019 - 06/2016
3	omega-Chloroacetophenone (Mace)IBA 03/2018 - 04/2010
3	AntibodiesIBA 01/2018 - 07/2013
3	Interleukin-13IBA 01/2015 - 12/2009
2	AnthracyclinesIBA 04/2024 - 11/2019
2	amsonic acid (DAS)IBA 02/2024 - 01/2020
2	Circular RNAIBA 12/2023 - 01/2018
2	Mitochondrial DNA (mtDNA)IBA 12/2023 - 09/2017
2	pirarubicinIBA 09/2023 - 08/2023
2	Gemcitabine FDA Link 09/2023 - 08/2023
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2023 - 03/2006
2	RotenoneIBA 04/2023 - 03/2021
2	MicroRNAs (MicroRNA)IBA 03/2023 - 04/2016
2	InflammasomesIBA 01/2023 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2011
2	CollagenIBA 01/2023 - 06/2016
2	Dopamine Receptors (Dopamine Receptor)IBA 12/2022 - 01/2022
2	Biocompatible Materials (Biomaterials)IBA 10/2022 - 01/2022
2	InterferonsIBA 08/2022 - 01/2022
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 08/2022 - 01/2022
2	Prostate-Specific Antigen (Semenogelase)IBA 03/2022 - 02/2021
2	CD100 antigenIBA 01/2022 - 01/2021
2	Nerve Growth Factors (Neurotrophins)IBA 01/2022 - 01/2020
2	Dopamine D3 ReceptorsIBA 01/2022 - 10/2018
2	2-vanillinIBA 11/2021 - 01/2021
2	LigandsIBA 11/2021 - 01/2021
2	Schiff Bases (Schiff Base)IBA 11/2021 - 01/2021
2	VALD-3IBA 11/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2021 - 12/2010
2	Beclin-1IBA 01/2021 - 01/2019

Therapy/Procedure

17	Therapeutics 01/2023 - 12/2006
8	Drug Therapy (Chemotherapy) 04/2024 - 04/2007
4	Aftercare (After-Treatment) 05/2017 - 07/2003
3	Radiotherapy 01/2021 - 04/2007
3	Percutaneous Coronary Intervention 03/2018 - 04/2010
2	Immunotherapy 10/2023 - 05/2022